Encouragingly, this study further validates the recent findings published by us, which indicated that CN-AML patients with DDX11 mutations have a significantly higher CIR and poorer LFS [36], and DDX11 dysfunctions were linked to AML via promoting cell proliferation [37]. This evidence concerns the gene DDX11 and acute myeloid leukemia.